Vulvovaginal Candidiasis and its Antifungal Susceptibility Pattern: Single center experience
Ruchi Rati, Jaya Patel, Suman Rishi
openalex +1 more source
Aetiology of Vulvovaginal Candidiasis in Ecuador and In Vitro Antifungal Activity Against <i>Candida</i> Vaginal Isolates. [PDF]
Bowen C +6 more
europepmc +1 more source
<i>Mitracarpus frigidus</i> in the Treatment of Vulvovaginal Candidiasis: A Comprehensive Evaluation of Its Therapeutic Properties. [PDF]
Souza TF +20 more
europepmc +1 more source
Study on the impact of biofilm formation by <i>Candida albicans</i> in recurrent vulvovaginal candidiasis on drug susceptibility. [PDF]
Li S, Shen Z, Wang S, Peng Y, Qi W.
europepmc +1 more source
New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections. [PDF]
De Seta F, Warris A, Roselletti E.
europepmc +1 more source
Gaze-DETR: Using Expert Gaze to Reduce False Positives in Vulvovaginal Candidiasis Screening [PDF]
Yan Kong +7 more
openalex +1 more source
Migration and standing variation in vaginal and rectal yeast populations in recurrent vulvovaginal candidiasis. [PDF]
Adamu Bukari A-R +8 more
europepmc +1 more source
Regulatory gaps in over-the-counter antifungal access for vulvovaginal candidiasis in Uganda: A policy analysis framework. [PDF]
Jonani B, Kwizera R.
europepmc +1 more source
Standardizing Vulvovaginal candidiasis diagnosis in Uganda: A case for British Association for Sexual Health and HIV 2019 guidelines. [PDF]
Jonani B.
europepmc +1 more source

